Silent thyroiditis medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{MMF}} | {{CMG}}; {{AE}} {{MMF}} | ||
==Overview== | ==Overview== | ||
Pharmacologic medical therapies for silent thyroiditis include beta blockers for thyrotoxicosis symptoms and [[Levothyroxine]] | Pharmacologic medical therapies for silent thyroiditis include beta blockers for thyrotoxicosis symptoms and [[Levothyroxine]] for the [[hypothyroidism]] if it follows the [[hyperthyroid]] state.<ref name="pmid22443972">{{cite journal |vauthors=Samuels MH |title=Subacute, silent, and postpartum thyroiditis |journal=Med. Clin. North Am. |volume=96 |issue=2 |pages=223–33 |year=2012 |pmid=22443972 |doi=10.1016/j.mcna.2012.01.003 |url=}}</ref><ref name="pmid7630839">{{cite journal |vauthors=Schubert MF, Kountz DS |title=Thyroiditis. A disease with many faces |journal=Postgrad Med |volume=98 |issue=2 |pages=101–3, 107–8, 112 |year=1995 |pmid=7630839 |doi= |url=}}</ref><ref name="pmid1987447">{{cite journal |vauthors=Singer PA |title=Thyroiditis. Acute, subacute, and chronic |journal=Med. Clin. North Am. |volume=75 |issue=1 |pages=61–77 |year=1991 |pmid=1987447 |doi= |url=}}</ref> | ||
==Medical Therapy== | ==Medical Therapy== | ||
Revision as of 13:30, 21 September 2017
|
Silent thyroiditis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Silent thyroiditis medical therapy On the Web |
|
American Roentgen Ray Society Images of Silent thyroiditis medical therapy |
|
Risk calculators and risk factors for Silent thyroiditis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Furqan M M. M.B.B.S[2]
Overview
Pharmacologic medical therapies for silent thyroiditis include beta blockers for thyrotoxicosis symptoms and Levothyroxine for the hypothyroidism if it follows the hyperthyroid state.[1][2][3]
Medical Therapy
Silent thyroiditis
The drugs used in the treatment of silent are:
- For thyrotoxic symptoms
- Preferred regimen (1):atenolol: 25-200mg per day orally
- Preferred regimen (2):metoprolol: 25-200mg per day orally
- For hypothyroidism
- Preferred regimen (1):Synthetic levothyroxine (L-T4): 1.6–1.8 μg/kg per day orally
References
- ↑ Samuels MH (2012). "Subacute, silent, and postpartum thyroiditis". Med. Clin. North Am. 96 (2): 223–33. doi:10.1016/j.mcna.2012.01.003. PMID 22443972.
- ↑ Schubert MF, Kountz DS (1995). "Thyroiditis. A disease with many faces". Postgrad Med. 98 (2): 101–3, 107–8, 112. PMID 7630839.
- ↑ Singer PA (1991). "Thyroiditis. Acute, subacute, and chronic". Med. Clin. North Am. 75 (1): 61–77. PMID 1987447.